The long and short of chromosome 11 in breast cancer.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

13 citing papers in PubMed.

1. Single-Sample Networks Reveal Intra-Cytoband Co-Expression Hotspots in Breast Cancer Subtypes.International journal of molecular sciences · 2024
   Article
2. Absence of lobular carcinoma in situ is a poor prognostic marker in invasive lobular carcinoma.European journal of cancer (Oxford, England : 1990) · 2023
   Article
3. Effects of Human Papilloma Virus E6/E7 Oncoproteins on Genomic Structure in Head and Neck Squamous Cell Carcinoma.Cancers · 2022
   Article
4. Association Analysis of Methylenetetrahydrofolate Reductase Common Gene Polymorphisms with Breast Cancer Risk in an Iranian Population: A Case-Control Study and a Stratified Analysis.Asian Pacific journal of cancer prevention : APJCP · 2020
   Article
5. Chemotherapy Controls Metastasis Through Stimulatory Effects on GRP78 and Its Transcription Factor CREB3L1.Frontiers in oncology · 2020
   Article
6. miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer.Cancer research · 2016
   Article
7. Epigenetic silencing of CREB3L1 by DNA methylation is associated with high-grade metastatic breast cancers with poor prognosis and is prevalent in triple negative breast cancers.Breast cancer research : BCR · 2016
   Article
8. Phospho-histone H2AX is a diagnostic and prognostic marker for epithelial ovarian cancer.International journal of clinical and experimental pathology · 2015
   Article
9. miR-24-2 controls H2AFX expression regardless of gene copy number alteration and induces apoptosis by targeting antiapoptotic gene BCL-2: a potential for therapeutic intervention.Breast cancer research : BCR · 2011
   Article
10. Significance of lobular intraepithelial neoplasia at margins of breast conservation specimens: a report of 38 cases and literature review.Diagnostic pathology · 2010
    Review
11. Predictors of contralateral breast cancer in patients with unilateral breast cancer undergoing contralateral prophylactic mastectomy.Cancer · 2009
    Article
12. The role of microsatellite instability at chromosome 11p15.5 in the progression of breast ductal carcinoma.Journal of Korean medical science · 2004
    Article
13. Allelic loss on chromosome band 18p11.3 occurs early and reveals heterogeneity in breast cancer progression.Breast cancer research : BCR · 2001
    Article

Corrections and comments

• Comment on
  Loss of heterozygosity on chromosome 11p15 during histological progression in microdissected ductal carcinoma of the breast.1998

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as